Time Source Company Announcement
13 Mar 2026 01:00 PM Annual Financial Report
13 Mar 2026 12:57 PM EXERCISE OF SHARE OPTIONS
13 Mar 2026 12:46 PM Issue of Equity
13 Mar 2026 12:41 PM Director/PDMR Shareholding
13 Mar 2026 12:39 PM Transaction in Own Shares
13 Mar 2026 12:33 PM Holding(s) in Company
13 Mar 2026 12:31 PM Bitcoin Purchase
13 Mar 2026 12:30 PM Director/PDMR Shareholding
13 Mar 2026 12:27 PM Director/PDMR Shareholding
13 Mar 2026 12:27 PM Holding(s) in Company
13 Mar 2026 12:16 PM Notification of Major Holdings
13 Mar 2026 12:11 PM Annual Financial Report
13 Mar 2026 12:00 PM Appointment of Joint Corporate Broker
13 Mar 2026 12:00 PM Company Secretary Change
13 Mar 2026 11:57 AM Exercise of Warrants
13 Mar 2026 11:51 AM Final Results for year ended 31 March 2025
13 Mar 2026 11:48 AM Holding(s) in Company
13 Mar 2026 11:46 AM Director/PDMR Shareholding
13 Mar 2026 11:45 AM Form 38.5b - PERMANENT TSB GROUP HOLDINGS PLC
13 Mar 2026 11:45 AM Form 38.5b - PERMANENT TSB GROUP HOLDINGS PLC
13 Mar 2026 11:44 AM Notice of General Meeting
13 Mar 2026 11:44 AM Form 38.5a - PERMANENT TSB GROUP HOLDINGS PLC
13 Mar 2026 11:35 AM Form 8.3 - Permanent TSB Group Holdings Plc
13 Mar 2026 11:35 AM Holding(s) in Company
13 Mar 2026 11:35 AM Grant of Share Options
13 Mar 2026 11:32 AM Holding(s) in Company
13 Mar 2026 11:31 AM Holding(s) in Company
13 Mar 2026 11:30 AM Annual Report and Notice of Annual General Meeting
13 Mar 2026 11:24 AM Holding(s) in Company
13 Mar 2026 11:16 AM Director/PDMR Shareholding
13 Mar 2026 11:12 AM Stonepark Zinc Project - Drilling Update
13 Mar 2026 11:12 AM Director/PDMR Shareholding - acquisition of shares
13 Mar 2026 11:07 AM Final Terms
13 Mar 2026 11:06 AM Final Terms
13 Mar 2026 11:04 AM Half-year Financial Report to 30 September 2024
13 Mar 2026 11:01 AM Holding(s) in Company
13 Mar 2026 11:00 AM Transaction in Own Shares
13 Mar 2026 11:00 AM Holding(s) in Company
13 Mar 2026 11:00 AM Holding(s) in Company
13 Mar 2026 10:38 AM TR1: Notification of Major Holdings
13 Mar 2026 10:31 AM US FDA approves Arexvy for adults 18-49 AIR
13 Mar 2026 10:29 AM Director/PDMR Shareholding
13 Mar 2026 10:27 AM Recording of Strategic Investment Presentation
13 Mar 2026 10:14 AM Transaction in Own Shares
13 Mar 2026 10:13 AM Public Opening Position Disclosure
13 Mar 2026 10:11 AM Transfer of Shares to AI Board Adviser and TVR
13 Mar 2026 10:00 AM Fundraise
13 Mar 2026 10:00 AM Loan to NYCE International Plc
13 Mar 2026 10:00 AM Holding(s) in Company
13 Mar 2026 10:00 AM Director/PDMR Shareholding
UK 100

Latest directors dealings